| RS137854861 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudoexfoliation glaucoma, Weill-Marchesani syndrome |
| RS137854863 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary open angle glaucoma, Microspherophakia and/or megalocornea |
| RS137854876 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137854877 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137854879 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, TSC2-related disorder |
| RS137854880 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137854882 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS137854886 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudoexfoliation glaucoma, Weill-Marchesani syndrome |
| RS137854887 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome |
| RS137854888 |
DNAJC19
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 5, DNAJC19-related disorder |
| RS137854889 |
ZMPSTE24
|
Health Risk |
Pathogenic |
Mandibuloacral dysplasia with type B lipodystrophy, Lethal tight skin contracture syndrome |
| RS137854890 |
TYR
|
Health Risk |
Likely pathogenic |
Oculocutaneous albinism type 1A, SKIN/HAIR/EYE PIGMENTATION 3 |
| RS137854891 |
ABCG8
|
Health Risk |
Pathogenic |
Sitosterolemia 1, Sitosterolemia 1 |
| RS137854895 |
LTBP2
|
Health Risk |
Pathogenic |
Glaucoma 3, primary congenital |
| RS137854907 |
ARL6
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 3 |
| RS137855422 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 2B, Multiple endocrine neoplasia type 2A |
| RS1378555453 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS137855767 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS137856939 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS137857342 |
PLOD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS137858712 |
GPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, Simpson-Golabi-Behmel syndrome type 1 |
| RS1378590183 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis type 1 |
| RS137859412 |
XPNPEP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis-like nephropathy 1, Nephronophthisis-like nephropathy 1 |
| RS137860025 |
GPR179
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1E, Congenital stationary night blindness 1E |
| RS137860047 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1378603446 |
HSD17B3
|
Health Risk |
Pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS137860861 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS137861347 |
PCCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS137862641 |
DNAAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1378646156 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS137865262 |
APP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease, Alzheimer disease |
| RS1378659602 |
CCDC88C
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 40, Hydrocephalus |
| RS1378662017 |
F8
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1378663182 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS1378664671 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS137866968 |
PNPLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS1378679640 |
GJB2
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, 7 conditions |
| RS1378679988 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS137868043 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS137868047 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Transitory neonatal diabetes mellitus |
| RS137868143 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder 1 |
| RS137868226 |
IL7R
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, Immunodeficiency 104 |
| RS137868356 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS137868995 |
MYMK
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital nonprogressive myopathy with Moebius and Robin sequences, Carey-Fineman-Ziter syndrome 1 |
| RS137869198 |
PHKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1378695952 |
CYP21A2
|
Health Risk |
Pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS137869655 |
PTPRC
|
Health Risk |
Likely pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS137870461 |
KCNJ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Andersen Tawil syndrome, Atrial fibrillation |
| RS137870876 |
PAX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukemia, acute lymphoblastic |
| RS137871407 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS137871492 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Inborn genetic diseases |
| RS137871935 |
SEMA3A
|
Health Risk |
Conflicting classifications of pathogenicity |
SEMA3A-related disorder, Hypogonadotropic hypogonadism 16 with or without anosmia |
| RS137872361 |
FOXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
T-cell immunodeficiency, congenital alopecia |
| RS1378725834 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1378726802 |
TMEM237
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 14, Joubert syndrome 14 |
| RS137872711 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS137872925 |
KRT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS137873272 |
GDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS137873871 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS137874590 |
DDHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia |
| RS137874743 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Familial dysautonomia |
| RS137875230 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS137875815 |
ODAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 20 |
| RS137876115 |
ABRAXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS137876156 |
NAXD
|
Health Risk |
Conflicting classifications of pathogenicity |
NAD(P)HX dehydratase deficiency, NAD(P)HX dehydratase deficiency |
| RS137876961 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 15, Retinal dystrophy |
| RS137877018 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, Biotinidase deficiency |
| RS1378771732 |
DENND5A
|
Health Risk |
Likely pathogenic |
DENND5A-related disorder, DENND5A-related disorder |
| RS137877289 |
GRK1
|
Health Risk |
Pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS137877386 |
APC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Cortical dysplasia |
| RS137877445 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Ciliary dyskinesia, primary |
| RS137878131 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS137878146 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS137878385 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1378786011 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS137878640 |
TDRD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 36, Inborn genetic diseases |
| RS1378791199 |
DIAPH1
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS137879324 |
ANOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS1378794678 |
SERPINA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS1378797018 |
DOCK3
|
Health Risk |
Likely pathogenic |
DOCK3-related disorder, DOCK3-related disorder |
| RS1378799607 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinal dystrophy |
| RS137880635 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS137880855 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Gorlin syndrome |
| RS1378815381 |
CHST3
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS1378818859 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS137882210 |
CLDN16
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hypomagnesemia, Primary hypomagnesemia |
| RS137882374 |
GH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Decreased response to growth hormone stimulation test, Decreased response to growth hormone stimulation test |
| RS137882485 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS137882536 |
LRP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 17, Cenani-Lenz syndactyly syndrome |
| RS1378826651 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, Autosomal dominant nonsyndromic hearing loss 4A |
| RS1378830983 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS137883250 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS137883370 |
PKD1L1
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS137884184 |
ELF4
|
Health Risk |
Pathogenic |
See cases, Acute myeloid leukemia |
| RS1378842608 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS137884710 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS137885421 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, Inborn genetic diseases |
| RS137886095 |
HEPACAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts, Megalencephalic leukoencephalopathy with subcortical cysts |
| RS137886124 |
SAG
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 96 |
| RS137886182 |
NUP160
|
Health Risk |
Conflicting classifications of pathogenicity |
— |